Table 2.

Summary of findings from the retrospective study used for this review.

Author	Study population/Sample size	Renal disease implicated	Summary
Ganesan et al, 2017[1]	Patients at a large, urban academic tertiary care center and its satellite facilities/118 MS patients with stone disease. Out of these 118, 61 MS patients had a complete 24-h urinary stone panel analysis.	Nephrolithiasis	Compared to the control group, patients with MS were significantly more likely to have calcium phosphate stones (42% vs 15%, P < .001) and struvite stones (8% vs 3%, P = .03) and less likely to have calcium oxalate monohydrate stones (39% vs 64%, P < .001). -Use of intermittent straight catheterization (OR, 3.50 [95% CI, 1.89–6.47]; P = < 0.001) or an indwelling catheter (OR, 9.78 [95% CI, 4.81–19.88]; P = <0.001) for bladder emptying was significantly associated with stone disease.

CI = confidence interval, MS = Multiple sclerosis, p = P-value, vs = versus.